Comparison of BPAP ST/T and BPAP ST / T Mode With AVAPS for Hypercapnic Respiratory Failure in ED
Dokuz Eylul University School of Medicine
1 other identifier
interventional
80
1 country
1
Brief Summary
The aim of the present study; To compare the effects of respiratory support options available for NIMV at the emergency department; i.e. AVAPS and ST/T modes, on the patient's pCO2 values, additional treatment need (another non-invasive ventilation method or endotracheal intubation) and the duration of stay in hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 20, 2016
CompletedFirst Submitted
Initial submission to the registry
November 30, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 20, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedFirst Posted
Study publicly available on registry
January 12, 2018
CompletedJanuary 12, 2018
January 1, 2018
9 months
November 30, 2016
January 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PaCO2 values
Will measure change in PaCO2 values in the blood gase analysis of patients comparing those treated with BPAP ST/T and those with AVAPS
On arrival, at one hour, and at two hourly intervals thereafter
Secondary Outcomes (3)
Failure of treatment options
During the treatment
Length of hospital stay
up to 6 months
The time of treatment
During the treatment
Study Arms (2)
BPAP ST/T
ACTIVE COMPARATORNon-invasive Ventilation with BPAP ST/T mode
AVAPS
EXPERIMENTALNon-invasive Ventilation with AVAPS mode
Interventions
Eligibility Criteria
You may qualify if:
- PaCO2 \> 45mmHg and any of the following
- SaO2 \<90% on air
- SaO2 \<93% on \>6 Litres O2/min
- Inability to speak in sentences due to respiratory distress
- Respiratory rate \> 24/min
- Altered mental status
- The use of accessory muscles of respiration
You may not qualify if:
- Respiratory arrest or unstable cardiorespiratory status
- Suspected Pneumothorax
- Urgent need for intubation
- Systolic blood pressure \< 90 mmHg
- Inability to protect airway
- Facial deformity
- Facial, esophageal, or gastric surgery history
- All trauma patients
- Acute myocardial infarction
- Severe arrythmias
- Refractory nausea and vomiting
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dokuz Eylul University Hospital
Izmir, 35340, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Başak Bayram, MD
Dokuz Eylul University, School of Medicine, Department of Emergency Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor Dr.
Study Record Dates
First Submitted
November 30, 2016
First Posted
January 12, 2018
Study Start
October 20, 2016
Primary Completion
July 20, 2017
Study Completion
August 1, 2017
Last Updated
January 12, 2018
Record last verified: 2018-01